Episode
Innovating in Women’s Health | Marina from Mimark Diagnostics at the EIC Scaling Club Ambition Forum
- Published
- Oct 17, 2025
- Duration seconds
- 317
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/e7a4b689
Actions
POST https://stenobird.com/v1/public/podcasts/the-eic-scaling-club-podcast-on-european-deep-tech-6612255/episodes/innovating-in-women-s-health-marina-from-mimark-diagnostics-at-the-eic-scaling-club-ambition-forum/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-eic-scaling-club-podcast-on-european-deep-tech-6612255/innovating-in-women-s-health-marina-from-mimark-diagnostics-at-the-eic-scaling-club-ambition-forum.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this interview, Marina, CEO and Co-founder of Mimark Diagnostics, shares her mission to transform women’s health through innovative diagnostic solutions. Founded in 2021 in Barcelona, Mimark Diagnostics is a women-led medtech company developing non-invasive diagnostic tests based on gynecological liquid biopsies. Their first product, a test for early endometrial cancer detection, is now moving into clinical and regulatory validation after completing a national investigational study across 20 sites in Spain, involving nearly 2,000 patients. Marina also discusses the company’s growth journey, highlighting support from EIT Health, the EIC, and private investors. Through the EIC Scaling Club, Mimark has received valuable mentoring and strategic guidance to expand its portfolio into new areas such as endometriosis diagnostics. This interview was recorded on 3 September 2025, during the EIC Scaling Club Ambition Forum at the University of Latvia in Riga.